EUVIMEDOpdag EUVIMED
Leserbrief

Dupilumab Add‐On Therapy in Severe Refractory Darier Disease

Nedim Uysal iD, Anıl Çağrı Tuna iD, Ayşenur Botsalı iD

International Journal of Dermatology · 2026-07-14

DOI: 10.1111/ijd.70583 ↗

At a glance

Leserbrief in International Journal of Dermatology, published online on 2026-07-14. Written by Nedim Uysal and 2 co-authors. Institution: Dermatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye. 5 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

Darier diseaseacitretindupilumabmethicillin‐resistant Staphylococcus aureuspruritus

Authors and institutions

  • Dermatology Department, Gülhane Training and Research Hospital, Ankara, Türkiye.

ORCID profiles: Nedim Uysal, Anıl Çağrı Tuna, Ayşenur Botsalı

Cite

APA

Uysal, N., Tuna, A. Ç., & Botsalı, A. (2026). Dupilumab Add‐On Therapy in Severe Refractory Darier Disease. International Journal of Dermatology. https://doi.org/10.1111/ijd.70583

Vancouver

Uysal N, Tuna AÇ, Botsalı A. Dupilumab Add‐On Therapy in Severe Refractory Darier Disease. International Journal of Dermatology. 2026. doi:10.1111/ijd.70583

BibTeX
@article{Uysal2026,
  author = {Uysal, Nedim and Tuna, Anıl Çağrı and Botsalı, Ayşenur},
  title = {Dupilumab Add‐On Therapy in Severe Refractory Darier Disease},
  journal = {International Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ijd.70583}
}
Start for free →